ArticleIntractable & rare diseases research2025

Three-year real-world outcomes of lanadelumab prophylaxis in hereditary angioedema: Complete disease suppression and psychosocial benefits in two East Asian patients.

Saori Takamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.